Developing Data Collection Instruments - World Bank
103 8 Developing Data Collection Instruments M onitoring and evaluation rely on data collection instruments to elicit and record information. There are various types of instruments
Download Developing Data Collection Instruments - World Bank
Information
Domain:
Source:
Link to this page:
Documents from same domain
Introduction to the Insurance Industry - World Bank
siteresources.worldbank.orgIntroduction to the Insurance Industry primer series on insurance issue 1, march 2009 www.worldbank.org/nbfi Rodney Lester
Improving Primary Students’ Performance in Public …
siteresources.worldbank.orgImproving Student Performance in Public Primary Schools in Developing Countries: Evidence from Indonesia Daniel Suryadarma, Asep Suryahadi, Sudarno Sumarto
Practical Workshop for NBU Staff and Bankers …
siteresources.worldbank.org7 IAS 39 Impairment calculation »Based on the previous table and assumptions, IAS 39 impairment is ….....? »What if we change the scenario: Within the
Rural Infrastructure and Agricultural Development …
siteresources.worldbank.org3 Agricultural Development is Essential for Economic Growth, Rural Development, and Poverty Alleviation Agriculture constitutes the core of the economy of most low-income developing countries.
The Political Economy of Decentralization Reforms
siteresources.worldbank.orgTHE POLITICAL ECONOMY OF DECENTRALIZATION REFORMS: IMPLICATIONS FOR AID EFFECTIVENESS * University of California-Santa …
Measuring Empowerment in Practice: Structuring …
siteresources.worldbank.org1 Measuring Empowerment in Practice: Structuring Analysis and Framing Indicators Ruth Alsop Nina Heinsohn World Bank Policy Research Working Paper 3510, February 2005
The Role of Information and Communication …
siteresources.worldbank.org1 Abstract The paper discusses the foundations for establishing a viable and sustainable Information and Communication Technology (ICT) industry and the opportunities
The FRESH M&E Framework - World Bank
siteresources.worldbank.orgThe FRESH M&E Framework A Generic Framework for Monitoring and Evaluation of School Health Interventions Draft-Version Updated 20 November 2010
Impact Evaluations Development - World Bank
siteresources.worldbank.orgiv Impact EvaluatIons and dEvElopmEnt – nonIE GuIdancE on Impact EvaluatIon 41 6 Build on existing knowledge relevant to the impact of interventions
A Review of the Role and Impact of Export …
siteresources.worldbank.orgA Review of the Role and Impact of Export Processing Zones August 1999 Dorsati Madani Address: PREM- EP The World Bank EM: dmadani@worldbank.org
Related documents
Sunoion Support
www.sunovionsupport.com2 Sunoion Support® PSPN ASSSAN PGAM Patient’s Insurance Information 1. Is the patient enrolled in Medicare/Medicaid? YES NO 2. Does the patient have prescription drug coverage through any other benefit program that helps pay for prescription
Dental management of patients before and after renal ...
www.sbdmj.comStomatologija, Baltic Dental and Maxillofacial Journal, 2011, Vol. 13, No. 4 107 Dental management of patients before and after renal transplantation
(OWTOIMPROVETHEUSEOF - WHO
www.who.inti (OWTOIMPROVETHEUSEOF MEDICINESBYCONSUMERS Andrew Chetley Healthlink Worldwide Anita Hardon University of Amsterdam Catherine Hodgkin Royal Tropical Institute, the Netherlands
Vaccine Fact Sheet - EZIZ
eziz.orgBrand Name Menactra Manufacturer Abbreviation MenACWY-CRM Protects Against Invasive Meningococcal Disease caused by Routine Schedule One (1) dose at …
Financial Section - Merck.com
www.merck.com20 Merck & Co., Inc. Annual Report 2002 live virus vaccine for the prevention of chickenpox, M-M-R II, a pediatric vaccine for measles, mumps and rubella, and
chapter 4 National medicine policy - WHO
apps.who.int4 / National medicine policy 4.3 stated: a national medicine policy should ensure that effec- tive and safe medicines of good quality are accessible and affordable to the entire population and that they are - ratio nally used. The 1980s saw the idea of an NMP emerging as a posi-tive concept, and the World Health Organization (WHO)
Generic and Brand Name Drugs: Understanding the Basics
www.dbsalliance.orgGeneric and Brand Name Drugs: Understanding the Basics We’ve been there. We can help.
contact - WHO
apps.who.intContact n°183 –Autumn/Winter 2006 3 EDITORIAL wards changing specific problems; the amount of irrational use, so that the size of the problem is known and the impact of the strategies can be moni-tored; the reasons why medicines are used irrationally, so that appropriate, effective